SOPHiA GENETICS Bilan de santé
Santé financière contrôle des critères 4/6
SOPHiA GENETICS has a total shareholder equity of $121.4M and total debt of $13.3M, which brings its debt-to-equity ratio to 11%. Its total assets and total liabilities are $181.1M and $59.7M respectively.
Informations clés
11.0%
Ratio d'endettement
US$13.34m
Dette
| Ratio de couverture des intérêts | n/a |
| Argent liquide | US$105.40m |
| Fonds propres | US$121.44m |
| Total du passif | US$59.65m |
| Total des actifs | US$181.10m |
Mises à jour récentes de la santé financière
Is SOPHiA GENETICS (NASDAQ:SOPH) A Risky Investment?
Oct 03
Here's Why We're Not Too Worried About SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation
Dec 27Is SOPHiA GENETICS (NASDAQ:SOPH) In A Good Position To Invest In Growth?
Aug 08Here's Why We're Watching SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation
Dec 15We're Hopeful That SOPHiA GENETICS (NASDAQ:SOPH) Will Use Its Cash Wisely
Jul 01We Think SOPHiA GENETICS (NASDAQ:SOPH) Can Afford To Drive Business Growth
Mar 10Recent updates
Is SOPHiA GENETICS (NASDAQ:SOPH) A Risky Investment?
Oct 03SOPHiA GENETICS SA (NASDAQ:SOPH) Just Reported, And Analysts Assigned A US$6.00 Price Target
Aug 09Investors Still Waiting For A Pull Back In SOPHiA GENETICS SA (NASDAQ:SOPH)
Aug 08SOPHiA GENETICS SA (NASDAQ:SOPH) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Mar 09Sophia Genetics: Breakthrough Potential In A Cautious Healthcare Sector
Feb 12Here's Why We're Not Too Worried About SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation
Dec 27Why Investors Shouldn't Be Surprised By SOPHiA GENETICS SA's (NASDAQ:SOPH) 35% Share Price Surge
Nov 09Is SOPHiA GENETICS (NASDAQ:SOPH) In A Good Position To Invest In Growth?
Aug 08Here's Why We're Watching SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation
Dec 15SOPHiA GENETICS partnering with Boundless Bio on oncogene cancer therapies
Sep 21SOPHiA Genetics GAAP EPS of -$0.39 in-line, revenue of $11.7M misses by $0.25M
Aug 09We're Hopeful That SOPHiA GENETICS (NASDAQ:SOPH) Will Use Its Cash Wisely
Jul 01SOPHiA GENETICS SA (NASDAQ:SOPH) Just Reported Earnings, And Analysts Cut Their Target Price
Mar 18We Think SOPHiA GENETICS (NASDAQ:SOPH) Can Afford To Drive Business Growth
Mar 10Here's Why We're Not Too Worried About SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation
Nov 24Analyse de la situation financière
Passif à court terme: SOPH's short term assets ($125.8M) exceed its short term liabilities ($28.6M).
Passif à long terme: SOPH's short term assets ($125.8M) exceed its long term liabilities ($31.0M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: SOPH has more cash than its total debt.
Réduire la dette: Insufficient data to determine if SOPH's debt to equity ratio has reduced over the past 5 years.
Bilan
Analyse des pistes de trésorerie
Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.
Piste de trésorerie stable: SOPH has sufficient cash runway for more than a year based on its current free cash flow.
Prévisions de trésorerie: Insufficient data to determine if SOPH has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.